2019 Social Enterprise Conference

2019 Social Enterprise Conference

Stacy Blain was a panelist at Columbia University’s Social Enterprise Conference.

WE NYC Conference

WE NYC Women in Tech Conference

Stacy Blain was a panelist at WE NYC’s annual summit, Female Founders Disrupting HealthTech, at the New York Genome Center.

NYU Female Founders Forum

NYU Female Founders Forum

Stacy presenting on April 12, 2019.

Concarlo News

Impact Journals: March 2019

Download the manuscript: Tyrosine Phosphorylation of p27Kip1 Correlates with Palbociclib Responsiveness in Breast Cancer Tumor Cells Grown in Explant Culture

Proactive Investors

Proactive Investors Interview

At the 11th Annual Biotech Showcase in San Francisco

Concarlo News

Women & Wealth Magazine: 18 Women to Watch in 2018

Features Dr. Stacy Blain, Co-Founder and Chief Scientific Officer, Concarlo Holdings

Concarlo News

SUNY Downstate Medical Center Press Release

SUNY Downstate Startup Company Secures Over $1 Million in Seed Funding Investment for Advancement of Proprietary Cancer Companion Diagnostic Test

Biotech Team

Newsday Business Article

LI venture capital fund invests in NYC biotech startup

Concarlo News

Impact Journals: Oncoscience May 2018

Download Stacy’s article: Targeting p27 tyrosine phosphorylation as a modality to inhibit CDK4 and CDK2 and cause cell cycle arrest in breast cancer cells.